Key facts
- This page summarizes Emily M. Leproust's Form 4 filing for Twist Bioscience Corp (TWST).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Nov 2026, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (""PSUs""). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a ""sell to cover"" transaction and do not represent discretionary trades by the Reporting Person.
Footnote F2
Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 16, 2026 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
Footnote F3
25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Footnote F4
Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.